Cargando…

QSAR study of anti-prion activity of 2-aminothiazoles

2-aminothiazoles is a class of compounds capable of treating life-threatening prion diseases. QSAR studies on a set of forty-seven 2-aminothiazole derivatives possessing anti-prion activity were performed using multivariate analysis, which comprised of multiple linear regression (MLR), artificial ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandi, Prasit, Nantasenamat, Chanin, Srungboonmee, Kakanand, Isarankura-Na-Ayudhya, Chartchalerm, Prachayasittikul, Virapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942791/
https://www.ncbi.nlm.nih.gov/pubmed/27418919
_version_ 1782442481476960256
author Mandi, Prasit
Nantasenamat, Chanin
Srungboonmee, Kakanand
Isarankura-Na-Ayudhya, Chartchalerm
Prachayasittikul, Virapong
author_facet Mandi, Prasit
Nantasenamat, Chanin
Srungboonmee, Kakanand
Isarankura-Na-Ayudhya, Chartchalerm
Prachayasittikul, Virapong
author_sort Mandi, Prasit
collection PubMed
description 2-aminothiazoles is a class of compounds capable of treating life-threatening prion diseases. QSAR studies on a set of forty-seven 2-aminothiazole derivatives possessing anti-prion activity were performed using multivariate analysis, which comprised of multiple linear regression (MLR), artificial neural network (ANN) and support vector machine (SVM). The results indicated that MLR afforded reasonable performance with a correlation coefficient (r) and root mean squared error (RMSE) of 0.9073 and 0.2977, respectively, as obtained from leave-one-out cross-validation (LOO-CV). More sophisticated learning methods such as SVM provided models with the highest accuracy with r and RMSE of 0.9471 and 0.2264, respectively, while ANN gave reasonable performance with r and RMSE of 0.9023 and 0.3043, respectively, as obtained LOO-CV calculations. Descriptor analysis from the regression coefficients of the MLR model suggested that compounds should be asymmetrical molecule with low propensity to form hydrogen bonds and high frequency of N content at topological distance 02 in order to provide good activities. Insights from QSAR studies is anticipated to be useful in the design of novel derivatives based on the 2-aminothiazole scaffold as potent therapeutic agents against prion diseases.
format Online
Article
Text
id pubmed-4942791
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Leibniz Research Centre for Working Environment and Human Factors
record_format MEDLINE/PubMed
spelling pubmed-49427912016-07-14 QSAR study of anti-prion activity of 2-aminothiazoles Mandi, Prasit Nantasenamat, Chanin Srungboonmee, Kakanand Isarankura-Na-Ayudhya, Chartchalerm Prachayasittikul, Virapong EXCLI J Original Article 2-aminothiazoles is a class of compounds capable of treating life-threatening prion diseases. QSAR studies on a set of forty-seven 2-aminothiazole derivatives possessing anti-prion activity were performed using multivariate analysis, which comprised of multiple linear regression (MLR), artificial neural network (ANN) and support vector machine (SVM). The results indicated that MLR afforded reasonable performance with a correlation coefficient (r) and root mean squared error (RMSE) of 0.9073 and 0.2977, respectively, as obtained from leave-one-out cross-validation (LOO-CV). More sophisticated learning methods such as SVM provided models with the highest accuracy with r and RMSE of 0.9471 and 0.2264, respectively, while ANN gave reasonable performance with r and RMSE of 0.9023 and 0.3043, respectively, as obtained LOO-CV calculations. Descriptor analysis from the regression coefficients of the MLR model suggested that compounds should be asymmetrical molecule with low propensity to form hydrogen bonds and high frequency of N content at topological distance 02 in order to provide good activities. Insights from QSAR studies is anticipated to be useful in the design of novel derivatives based on the 2-aminothiazole scaffold as potent therapeutic agents against prion diseases. Leibniz Research Centre for Working Environment and Human Factors 2012-08-15 /pmc/articles/PMC4942791/ /pubmed/27418919 Text en Copyright © 2012 Mandi et al. http://www.excli.de/documents/assignment_of_rights.pdf This is an Open Access article distributed under the following Assignment of Rights http://www.excli.de/documents/assignment_of_rights.pdf. You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Original Article
Mandi, Prasit
Nantasenamat, Chanin
Srungboonmee, Kakanand
Isarankura-Na-Ayudhya, Chartchalerm
Prachayasittikul, Virapong
QSAR study of anti-prion activity of 2-aminothiazoles
title QSAR study of anti-prion activity of 2-aminothiazoles
title_full QSAR study of anti-prion activity of 2-aminothiazoles
title_fullStr QSAR study of anti-prion activity of 2-aminothiazoles
title_full_unstemmed QSAR study of anti-prion activity of 2-aminothiazoles
title_short QSAR study of anti-prion activity of 2-aminothiazoles
title_sort qsar study of anti-prion activity of 2-aminothiazoles
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942791/
https://www.ncbi.nlm.nih.gov/pubmed/27418919
work_keys_str_mv AT mandiprasit qsarstudyofantiprionactivityof2aminothiazoles
AT nantasenamatchanin qsarstudyofantiprionactivityof2aminothiazoles
AT srungboonmeekakanand qsarstudyofantiprionactivityof2aminothiazoles
AT isarankuranaayudhyachartchalerm qsarstudyofantiprionactivityof2aminothiazoles
AT prachayasittikulvirapong qsarstudyofantiprionactivityof2aminothiazoles